L. Résultats-attendus-À-la-gastroscopie, .. La-spécificité-de-la-gastroscopie, and .. , 102 1.2.2. Les anomalies histologiques retrouvées, p.104

B. Le-bilan, 108 2.1.3. Le test respiratoire à l'urée marquée, p.110

.. Le-rôle-de-helicobacter-pylori-dans-la-dyspepsie-chronique, 118 3.1. La prévalence de Helicobacter pylori dans les pathologies digestives 118 3.1.1. La prévalence de Helicobacter pylori en cas de reflux gastro-oesophagien ... 118 3.1.2. La prévalence de Helicobacter pylori en cas de maladie ulcéreuse, p.120

.. La-recherche-secondaire-de-helicobacter-pylori, 125 3.3.1. Le choix de la méthode diagnostique non invasive 125 Le test respiratoire (c.f. chapitre 2.1.3.), p.126

L. 'éradication-de-helicobacter-pylori, .. Helicobacter-pylori, and .. , 127 Effet de l'éradication en cas de dyspepsie non explorée Effet de l'éradication de Helicobacter pylori sur le risque de cancer gastrique, p.132

.. Les-moyens-d-'éradication-de-helicobacter-pylori, 133 Le traitement de première ligne, p.134

.. Le-contrôle-de-l-'éradication, 135 3.5.1. Les moyens de contrôle de l'éradication, p.136

R. Hürlimann and V. Stenz, Gastroentérologie : Rome ressuscitée, Forum Med Suisse, vol.6, pp.1155-1162, 2006.

K. Musana, Y. S. Lang, and K. , Managing Dyspepsia in a Primary Care Setting, Clinical Medicine & Research, vol.4, issue.4, pp.337-379, 2006.
DOI : 10.3121/cmr.4.4.337

R. Weir and M. Backett, Studies of the epidemiology of peptic ulcer in a rural community: prevalence and natural history of dyspepsia and peptic ulcer., Gut, vol.9, issue.1, pp.75-83, 1968.
DOI : 10.1136/gut.9.1.75

L. Agreus, Natural history of dyspepsia, Gut, vol.50, issue.Supplement 4, pp.2-9, 2002.
DOI : 10.1136/gut.50.suppl_4.iv2

R. Jones and S. Lydeard, Prevalence of symptoms of dyspepsia in the community., BMJ, vol.298, issue.6665, pp.30-32, 1989.
DOI : 10.1136/bmj.298.6665.30

R. Jones, S. Lydeard, F. Hobbs, J. Kenkre, E. Williams et al., Dyspepsia in England and Scotland., Dyspepsia in England and Scotland, pp.401-406, 1990.
DOI : 10.1136/gut.31.4.401

N. Talley, A. Zinsmeister, C. Schleck, and L. Melton, Dyspepsia and dyspepsia subgroups: A population-based study, Gastroenterology, vol.102, issue.4, pp.1259-68, 1992.
DOI : 10.1016/0016-5085(92)90764-P

G. Holtmann, H. Goebell, and N. Talley, Dyspepsia in consulters and non-consulters, European Journal of Gastroenterology & Hepatology, vol.6, issue.10, 1994.
DOI : 10.1097/00042737-199410000-00014

L. Agreus, K. Svärdsudd, O. Nyren, and G. Tibblin, Irritable bowel syndrome and dyspepsia in the general population: Overlap and lack of stability over time, Gastroenterology, vol.109, issue.3, pp.671-80, 1995.
DOI : 10.1016/0016-5085(95)90373-9

N. Talley, P. Boyce, and M. Jones, Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population, Gut, vol.42, issue.5, pp.690-695, 1998.
DOI : 10.1136/gut.42.5.690

A. Haycox, T. Einarson, and A. Eggleston, The health economic impact of upper gastrointestinal symptoms in the general population : results from the Domestic/International Gastroenterology Surveillance Study (DIGEST), Scan J Gastroenterol, vol.231, issue.34, pp.38-47, 1999.

G. Bommelaer, M. Rouch, M. Dapoigny, D. Pais, P. Loisy et al., Epidemiologie des troubles intestinaux fonctionnels dans une population saine, Gastroenterol Clin Biol, vol.10, issue.1, pp.7-12, 1986.

G. Ben-cheikh, M. Hamed, and L. , Diagnostic en médecine générale de l'infection à Helicobacter pylori par le test respiratoire à l'urée 13 C : enquête auprès des praticiens Lorrains, Thèse : Med : UHP Nancy, 200311145.

R. Schlemper, S. Van-der-werf, J. Vandenbroucke, I. Biemond, and C. Lamers, Peptic Ulcer, Non-Ulcer Dyspepsia and Irritable Bowel Syndrome in the Netherlands and Japan, Scandinavian Journal of Gastroenterology, vol.92, issue.sup200, pp.33-41, 1993.
DOI : 10.1007/BF01395503

H. El-serag and N. Talley, The prevalence and clinical course of functional dyspepsia, Alimentary Pharmacology and Therapeutics, vol.43, issue.6, pp.643-654, 2004.
DOI : 10.1046/j.1365-2036.2003.01575.x

R. Jian, Comment explorer et traiter un malade dyspeptique ?, Gastroent??rologie Clinique et Biologique, vol.29, issue.8-9, pp.818-845, 2005.
DOI : 10.1016/S0399-8320(05)86353-5

R. Jones and S. Lydeard, Dyspepsia in the community : a follow-up study, Br J Clin Pract, vol.26, issue.2, pp.95-102, 1992.

N. Talley, A. Weaver, A. Zinsmeister, and J. Melton, Onset and Disappearance of Gastrointestinal Symptoms and Functional Gastrointestinal Disorders, American Journal of Epidemiology, vol.136, issue.2, pp.165-77, 1992.
DOI : 10.1093/oxfordjournals.aje.a116483

L. Kay and T. Jorgensen, Epidemiology of Upper Dyspepsia in a Random Population: Prevalence, Incidence, Natural History, and Risk Factors, Scandinavian Journal of Gastroenterology, vol.23, issue.1, pp.2-6, 1994.
DOI : 10.3109/00365528809093875

V. Meineche-schmidt and E. Krag, Dyspepsia in general practice in Denmark. A 1-year analysis of consulters in general practice, Scand J Prim Health Care, vol.16, issue.4, pp.216-237, 1998.

N. Talley and N. Vakil, American Gastroenterological Association Technical Review on the Evaluation of Dyspepsia, Gastroenterology, vol.129, issue.5, pp.1756-80, 2005.
DOI : 10.1053/j.gastro.2005.09.020

N. Talley, A. Zinsmeister, C. Schleck, and L. Melton, Smoking, alcohol, and analgesics in dyspepsia and among dyspepsia subgroups: lack of an association in a community., Gut, vol.35, issue.5, pp.619-643, 1994.
DOI : 10.1136/gut.35.5.619

G. Elta, E. Behler, and T. Colturi, Comparison of coffee intake and coffee-induced symptoms in patients with duodenal ulcer, nonulcer dyspepsia, and normal controls, Am J Gastroenterol, vol.85, issue.10, pp.1339-1381, 1990.

N. Talley, D. Mcneil, and D. Piper, Environmental factors and chronic unexplained dyspepsia, Digestive Diseases and Sciences, vol.25, issue.Suppl, pp.641-649, 1988.
DOI : 10.1002/cpt1979254481

L. Agreus, The Epidemiology of Functional Gastrointestinal Disorders, The European Journal of Surgery, vol.164, issue.0, pp.60-66, 1998.
DOI : 10.1080/11024159850191265

A. Quartero, M. Numans, M. Post, R. De-melker, and N. De-wit, One-year prognosis of primary care dyspepsia: predictive value of symptom pattern, Helicobacter pylori and GP management, European Journal of Gastroenterology & Hepatology, vol.14, issue.1, pp.55-60, 2002.
DOI : 10.1097/00042737-200201000-00010

V. Meineche-schmidt and T. Jörgensen, Fluctuation in dyspepsia subgroups over time. A three-year follow-up of patients consulting general practice for dyspepsia, Digestive and Liver Disease, vol.34, issue.5, pp.332-340, 2002.
DOI : 10.1016/S1590-8658(02)80126-8

N. Talley, A. Weaver, and A. Zinsmeister, Impact of functional dyspepsia on quality of life, Digestive Diseases and Sciences, vol.28, issue.suppl 195, pp.584-593, 1995.
DOI : 10.7326/0003-4819-116-2-129

R. Jian and B. Coffin, L'infection par Helicobacter pylori doit-elle être prise en compte chez un malade souffrant de dyspepsie?, Gastroenterol Clin Biol, vol.27, issue.3, pp.432-441, 2003.

P. Moayyedi and J. Mason, Clinical and economic consequences of dyspepsia in the community, Gut, vol.50, issue.Supplement 4, pp.10-12, 2002.
DOI : 10.1136/gut.50.suppl_4.iv10

L. Agreus and L. Borgquist, The Cost of Gastro-Oesophageal Reflux Disease, Dyspepsia and Peptic Ulcer Disease in Sweden, PharmacoEconomics, vol.35, issue.Suppl.11, pp.347-55, 2002.
DOI : 10.1080/003655200750023886

P. Moayyedi and J. Mason, Clinical and economic consequences of dyspepsia in the community, Gut, vol.50, issue.Supplement 4, pp.10-12, 2002.
DOI : 10.1136/gut.50.suppl_4.iv10

R. Valori, C. Brown, P. Strangeways, and M. Bradburn, Reducing community dyspepsia drug costs: a controlled trial, Gut, vol.49, issue.4, pp.495-501, 2001.
DOI : 10.1136/gut.49.4.495

P. Moayyedi, Helicobacter pylori test and treat strategy for young dyspeptic patients: new data, Gut, vol.50, issue.Supplement 4, pp.47-50, 2002.
DOI : 10.1136/gut.50.suppl_4.iv47

J. Kurata, A. Nogawa, and J. Everhart, A prospective study of dyspepsia in primary care, Digestive Diseases and Sciences, vol.47, issue.4, pp.797-803, 2002.
DOI : 10.1023/A:1014748202229

S. Grainger, H. Klass, M. Rake, and J. Williams, Prevalence of dyspepsia: the epidemiology of overlapping symptoms., Postgraduate Medical Journal, vol.70, issue.821, pp.154-61, 1994.
DOI : 10.1136/pgmj.70.821.154

N. Talley, A. Weaver, D. Tesmer, and A. Zinsmeister, Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy, Gastroenterology, vol.105, issue.5, pp.1378-86, 1993.
DOI : 10.1016/0016-5085(93)90142-Y

N. Talley, V. Stanghellini, R. Heading, K. Koch, J. Malagelada et al., Functional gastroduodenal disorders, Gut, vol.45, issue.Supplement 2, pp.37-42, 1999.
DOI : 10.1136/gut.45.2008.ii37

P. Bytzer, J. Hansen, O. Schaffalitzky-de-muckedall, and A. Malchow-moller, Predicting Endoscopic Diagnosis in the Dyspeptic Patient: The Value of Predictive Score Models, Scandinavian Journal of Gastroenterology, vol.110, issue.2
DOI : 10.1053/gast.1996.v110.agast960302

A. Thomson, A. Barkun, D. Armstrong, N. Chiba, R. White et al., The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study, Alimentary Pharmacology and Therapeutics, vol.122, issue.2, pp.1481-91, 2003.
DOI : 10.1053/gast.2002.33427

N. Talley, Dyspepsia management in the millennium: The death of test and treat?, Gastroenterology, vol.122, issue.5, pp.1521-1526, 2002.
DOI : 10.1053/gast.2002.33370

G. Tytgat, Role of endoscopy and biopsy in the work up of dyspepsia, Gut, vol.50, issue.Supplement 4, pp.13-16, 2002.
DOI : 10.1136/gut.50.suppl_4.iv13

A. Balian and . Internat-médecine, Hépato-gastro-entérologie, 2003.

M. Thumshirn, Pathophysiology of functional dyspepsia, Gut, vol.51, issue.Supplement 1, pp.63-69, 2002.
DOI : 10.1136/gut.51.suppl_1.i63

V. Stanghellini, M. Anit, B. Porro, G. Corinaldesi, R. Gasbarrini et al., Risk indicators of organic diseases in uninvestigated dyspepsia, European Journal of Gastroenterology & Hepatology, vol.11, issue.10, pp.1129-1163, 1999.
DOI : 10.1097/00042737-199910000-00009

V. Stanghellini, C. Tosetti, A. Paternico, D. Giorgio, R. Barbara et al., Predominant symptoms identify different subgroups in functional dyspepsia, The American Journal of Gastroenterology, vol.316, issue.182, pp.2080-2085, 1999.
DOI : 10.1016/0016-5085(94)90086-8

G. Sarnelli, P. Caenepeel, B. Geypens, J. Janssens, and J. Tack, Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia, The American Journal of Gastroenterology, vol.35, issue.4, pp.783-791, 2003.
DOI : 10.1136/gut.47.1.11

N. Talley, M. Verlinden, and M. Jones, Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia?, The American Journal of Gastroenterology, vol.39, issue.3, pp.1422-1430, 2001.
DOI : 10.1023/A:1018834025351

J. Tack, P. Caenepeel, B. Fischler, H. Piessevaux, and J. Janssens, Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia, Gastroenterology, vol.121, issue.3, pp.526-561, 2001.
DOI : 10.1053/gast.2001.27180

G. Boeckxstaens, D. Hirsch, B. Van-den-elzen, S. Heisterkamp, and G. Tytgat, Impaired drinking capacity in patients with functional dyspepsia: Relationship with proximal stomach function, Gastroenterology, vol.121, issue.5, pp.1054-63, 2001.
DOI : 10.1053/gast.2001.28656

E. Mayer and G. Gebhart, Basic and clinical aspects of visceral hyperalgesia, Gastroenterology, vol.107, issue.1, pp.271-93, 1994.
DOI : 10.1016/0016-5085(94)90086-8

A. George, M. Tsuchiyose, and C. Dooley, Sensitivity of the gastric mucosa to acid and duodenal contents in patients with nonulcer dyspepsia, Gastroenterology, vol.101, issue.1, pp.3-6, 1991.
DOI : 10.1016/0016-5085(91)90453-R

S. Nahon, V. Jouannaud, C. Poupardin, and P. Lahmek, Prise en charge diagnostique et th??rapeutique de l'infection ?? Helicobacter pylori, EMC - Gastro-ent??rologie, vol.3, issue.2, pp.21-31, 2008.
DOI : 10.1016/S1155-1968(08)40076-7

D. Korwin and J. Helicobacter-pylori, Helicobacter pylori, Gastroent??rologie Clinique et Biologique, vol.31, issue.12, pp.1110-1117, 2007.
DOI : 10.1016/S0399-8320(07)78346-X

M. Queiroz, D. Luzza, and F. , Epidemiology of Helicobacter pylori Infection, Helicobacter, vol.39, issue.s1, pp.1-5, 2006.
DOI : 10.1080/00365520510015917

G. Sarnelli, R. Cuomo, J. Janssens, and J. Tack, Symptom Patterns and Pathophysiological Mechanisms in Dyspeptic Patients with and Without Helicobacter pylori, Digestive Diseases and Sciences, vol.48, issue.12, pp.2229-2265, 2003.
DOI : 10.1023/B:DDAS.0000007856.71462.6c

F. Mearin, X. De-ribot, A. Balboa, A. Salas, M. Varas et al., Does Helicobacter pylori infection increase gastric sensitivity in functional dyspepsia?, Gut, vol.37, issue.1, pp.47-51, 1995.
DOI : 10.1136/gut.37.1.47

M. Thumshirn, M. Camilleri, S. Saslow, D. Williams, D. Burton et al., Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function, Gut, vol.44, issue.1, pp.55-64, 1999.
DOI : 10.1136/gut.44.1.55

P. Henningsen, T. Zimmermann, and H. Sattel, Medically Unexplained Physical Symptoms, Anxiety, and Depression, Psychosomatic Medicine, vol.65, issue.4, pp.528-561, 2003.
DOI : 10.1097/01.PSY.0000075977.90337.E7

M. Jones, L. Sharp, and M. Crowell, Psychosocial Correlates of Symptoms in Functional Dyspepsia, Clinical Gastroenterology and Hepatology, vol.3, issue.6, pp.521-529, 2005.
DOI : 10.1016/S1542-3565(05)00245-4

N. Talley, S. Fett, A. Zinsmeister, and L. Melton, Gastrointestinal tract symptoms and self-reported abuse: A population-based study, Gastroenterology, vol.107, issue.4, pp.1040-1049, 1994.
DOI : 10.1016/0016-5085(94)90228-3

I. Wilhelmsen, T. Haug, H. Ursin, and A. Berstad, Discriminant analysis of factors distinguishing patients with functional dyspepsia from patients with duodenal ulcer, Digestive Diseases and Sciences, vol.314, issue.suppl 128, pp.1105-1116, 1995.
DOI : 10.1016/S0016-5085(88)80006-4

N. Koloski, N. Talley, and P. Boyce, Does psychological distress modulate functional gastrointestinal symptoms and health care seeking? A prospective, community cohort study, The American Journal of Gastroenterology, vol.83, issue.4, pp.789-97, 2003.
DOI : 10.1016/0022-3956(86)90005-1

S. Howell and N. Talley, Does fear of serious disease predict consulting behaviour amongst patients with dyspepsia in general practice?, European Journal of Gastroenterology & Hepatology, vol.11, issue.8, pp.881-887, 1999.
DOI : 10.1097/00042737-199908000-00012

J. Hamilton, E. Guthrie, F. Creed, D. Thompson, and B. Tomensen, A randomized controlled trial of psychotherapy in patients with chronic functional dyspepsia, Gastroenterology, vol.119, issue.3, pp.661-669, 2000.
DOI : 10.1053/gast.2000.16493

B. Fischler, J. Tack, D. Gucht, V. Shkedy, Z. Persoons et al., Heterogeneity of symptom pattern, psychosocial factors, and pathophysiological mechanisms in severe functional dyspepsia, Gastroenterology, vol.124, issue.4, pp.903-913, 2003.
DOI : 10.1053/gast.2003.50155

N. Koloski, N. Talley, S. Huskic, and P. Boyce, Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia, Alimentary Pharmacology and Therapeutics, vol.41, issue.6, pp.841-851, 2003.
DOI : 10.1007/s001270050026

N. Talley, S. Phillips, B. Bruce, C. Twomey, A. Zinsmeister et al., Relation among personality and symptoms in nonulcer dyspepsia and the irritable bowel syndrome, Gastroenterology, vol.99, issue.2, pp.327-360, 1990.
DOI : 10.1016/0016-5085(90)91012-U

J. Delchier, Comment faire passer les nouvelles connaissances dans la pratique? (Editorial) Hépato-gastro, 2004.

P. Malfertheiner, F. Megraud, O. Morain, C. Bazzoli, F. El-omar et al., Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report, Gut, vol.56, issue.6, pp.772-781, 2007.
DOI : 10.1136/gut.2006.101634

W. Chey and B. Wong, American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection, The American Journal of Gastroenterology, vol.11, issue.2, pp.1808-1833, 2007.
DOI : 10.1111/j.1523-5378.2006.00436.x

D. Korwin and J. , Recommandations d'éradication de Helicobacter pylori en, Hépato-gastro, vol.15, issue.5, pp.363-70, 2008.

D. Korwin and J. , Helicobacter pylori, Gastroent??rologie Clinique et Biologique, vol.31, issue.12, pp.189-91, 2007.
DOI : 10.1016/S0399-8320(07)78346-X

A. Ford and P. Moayyedi, Current Guidelines for Dyspepsia Management, Digestive Diseases, vol.128, issue.3, pp.225-255, 2008.
DOI : 10.1155/2005/674607

H. Fergani and J. Fardy, ???Test and treat??? strategy for management of uninvestigated dyspepsia: A meta-analysis, Gastroenterology, vol.120, issue.5, p.89, 2001.
DOI : 10.1016/S0016-5085(08)80439-8

N. Chiba, V. Van-santen, O. Sinclair, P. Ferguson, R. Escobedo et al., Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment---Helicobacter pylori positive (CADET-Hp) randomised controlled trial, BMJ, vol.324, issue.7344, pp.1012-1019, 2002.
DOI : 10.1136/bmj.324.7344.1012

J. Allison, L. Hurley, R. Hiatt, T. Levin, L. Ackerson et al., A Randomized Controlled Trial of Test-and-Treat Strategy for Helicobacter pylori, Archives of Internal Medicine, vol.163, issue.10, pp.1165-71, 2003.
DOI : 10.1001/archinte.163.10.1165

G. Manes, A. Menchise, C. De-nucci, and A. Balzano, Empirical prescribing for dyspepsia, European Journal of Gastroenterology & Hepatology, vol.15, issue.7, p.1118, 2003.
DOI : 10.1097/00042737-200307000-00022

A. Heaney, J. Collins, R. Watson, R. Mcfarland, K. Bamford et al., A prospective randomised trial of a "test and treat" policy versus endoscopy based management in young Helicobacter pylori positive patients with ulcer-like dyspepsia, referred to a hospital clinic, Gut, vol.45, issue.2, pp.186-90, 1999.
DOI : 10.1136/gut.45.2.186

R. Laheij, J. Hermsen, J. Jansen, A. Horrevorts, R. Rongen et al., Empirical treatment followed by a test-and-treat strategy is more cost-effective in comparison with prompt endoscopy or radiography in patients with dyspeptic symptoms: a randomized trial in a primary care setting, Family Practice, vol.21, issue.3, pp.238-281, 2004.
DOI : 10.1093/fampra/cmh304

N. Arents, J. Thijs, A. Van-zwet, M. Pool, J. Götz et al., Approach to Treatment of Dyspepsia in Primary Care, Archives of Internal Medicine, vol.163, issue.13, pp.1606-1618, 2003.
DOI : 10.1001/archinte.163.13.1606

A. Lassen, M. Pedersen, F. Bytzer, P. Schaffalitzky-de-muckadell, and O. , Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial, The Lancet, vol.356, issue.9228, pp.455-60, 2000.
DOI : 10.1016/S0140-6736(00)02553-8

K. Mckoll, L. Murray, D. Gillen, A. Walker, and A. Wirtz, Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H pylori testing alone in the management of dyspepsia, BMJ, vol.324, issue.7344, pp.999-1006, 2002.
DOI : 10.1136/bmj.324.7344.999

R. Jones, C. Tait, G. Sladen, and J. Weston-baker, A trial of a test-and-treat strategy for Helicobacter pylori positive dyspeptic patients in general practice, Int J Clin Pract, vol.53, issue.6, pp.413-419, 1999.

B. Delaney, P. Moayyedi, and D. Forman, Initial Management strategies for dyspepsia, Cochrane Database Syst Rev, issue.2, p.1961, 2003.

M. Silverstein, T. Petterson, and N. Talley, Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia, European Journal of Gastroenterology & Hepatology, vol.8, issue.3, pp.72-83, 1996.
DOI : 10.1097/00042737-199603000-00021

A. Fendrick, M. Chernew, R. Hirth, and B. Bloom, Alternative Management Strategies for Patients with Suspected Peptic Ulcer Disease, Annals of Internal Medicine, vol.123, issue.4, pp.260-268, 1995.
DOI : 10.7326/0003-4819-123-4-199508150-00003

J. Ofman, J. Etchason, S. Fullerton, C. Kahn, and A. Soll, Management Strategies for Helicobacter pylori-Seropositive Patients with Dyspepsia: Clinical and Economic Consequences, Annals of Internal Medicine, vol.126, issue.4, pp.280-91, 1997.
DOI : 10.7326/0003-4819-126-4-199702150-00004

B. Spiegel, N. Vakil, and J. Ofman, Dyspepsia management in primary care: A decision analysis of competing strategies, Gastroenterology, vol.122, issue.5, pp.1270-85, 2002.
DOI : 10.1053/gast.2002.33019

U. Ladabaum, M. Fendrick, D. Glidden, and J. Scheiman, Helicobacter pylori test-and-treat intervention compared to usual care in primary care patients with suspected peptic ulcer disease in the United States, The American Journal of Gastroenterology, vol.120, issue.12, pp.3007-3021, 2002.
DOI : 10.1136/bmj.321.7262.659

A. Sonnenberg, Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic subjects, Am J Gastroenterol, vol.91, issue.9, pp.1773-1780, 1996.

J. Hammer, G. Eslick, S. Howell, E. Altiparmak, and J. Talley, Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia, Gut, vol.53, issue.5, pp.666-72, 2004.
DOI : 10.1136/gut.2003.021857

M. Wallace, V. Durkalski, J. Vaughan, I. Palesch, E. Libby et al., Age and alarm symptoms do not predict endoscopic findings among patients with dyspepsia: a multicentre database study, Gut, vol.49, issue.1, pp.29-34, 2001.
DOI : 10.1136/gut.49.1.29

M. Foster and S. Attwood, Current guidelines fail young patients with oesophagogastric cancer, Gut, vol.51, issue.2, pp.296-97, 2002.
DOI : 10.1136/gut.51.2.296-a

J. Christie, N. Shepard, B. Codling, and R. Valori, Gastric cancer below the age of 55: implications for screening patients with uncomplicated dyspepsia, Gut, vol.41, issue.4, pp.513-520, 1997.
DOI : 10.1136/gut.41.4.513

Y. Yuan, I. Padol, and R. Hunt, Peptic ulcer disease today, Nature Clinical Practice Gastroenterology & Hepatology, vol.128, issue.Suppl 1, 2006.
DOI : 10.1053/j.gastro.2005.01.009

B. Delaney, S. Wilson, A. Roalfe, L. Roberts, V. Redman et al., Randomised controlled trial of Helicobacter pylori testing and endoscopy for dyspepsia in primary, BMJ, vol.322, issue.7291, pp.898-901, 2001.
DOI : 10.1136/bmj.322.7291.898

P. Phull, C. Salmon, K. Park, T. Rapson, A. Thompson et al., Age threshold for endoscopy and risk of missing upper gastrointestinal malignancy - data from the Scottish audit of gastric and oesophageal cancer, Alimentary Pharmacology and Therapeutics, vol.36, issue.2, pp.229-262, 2006.
DOI : 10.1016/S0140-6736(88)90879-3

N. Breslin, A. Thomson, R. Bailey, P. Blustein, J. Meddings et al., Gastric cancer and other endoscopic diagnoses in patients with benign dyspepsia, Gut, vol.46, issue.1, pp.93-100, 2000.
DOI : 10.1136/gut.46.1.93

C. Canga and N. Vakil, Upper GI malignancy, uncomplicated dyspepsia, and the age threshold for early endoscopy, The American Journal of Gastroenterology, vol.114, issue.182, pp.600-603, 2002.
DOI : 10.1016/S0002-9270(98)00655-8

D. Gillen and K. Mccoll, Does concern about missing malignancy justify endoscopy in uncomplicated dyspepsia in patients less than 55?, Gut, vol.94, issue.1, pp.75-84, 1999.

B. Delaney, S. Wilson, A. Roalfe, L. Roberts, V. Redman et al., Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: a randomised controlled trial in primary care, The Lancet, vol.356, issue.9246, pp.1965-1974, 2000.
DOI : 10.1016/S0140-6736(00)03308-0

M. Voutilainen, T. Mäntynen, I. Kunnamo, M. Juhola, J. Mecklin et al., Impact of clinical symptoms and referral volume on endoscopy for detecting peptic ulcer and gastric neoplasm, Scand J Gastroenterol, vol.38, issue.1, pp.109-122, 2003.

N. Talley, Yield of endoscopy in dyspepsia and concurrent treatment with proton pump inhibitors: The blind leading the blind?, Gastrointestinal Endoscopy, vol.58, issue.1, pp.89-92, 2003.
DOI : 10.1067/mge.2003.302

F. Bazzoli, D. Palli, R. Zagari, D. Festi, P. Pozzato et al., The Loiano-Monghidoro population-based study of Helicobacter pylori infection: prevalence by 13C-urea breath test and associated factors, Alimentary Pharmacology and Therapeutics, vol.103, issue.7, pp.1001-1008, 2001.
DOI : 10.1016/0016-5085(92)90004-I

D. Armstrong, Helicobacter pylori infection and dyspepsia, Scand J Gastroenterol, vol.215, pp.38-47, 1996.

D. Korwin and J. , Avantages et inconvéniants des différentes méthodes diagnostiques de l'infection à H. pylori, Gastroenterol Clin Biol, vol.27, pp.380-90, 2003.

J. Everhart, D. Kruszon-moran, G. Perez-perez, S. Tralka, T. Mcquillan et al., Infection among Adults in the United States, The Journal of Infectious Diseases, vol.181, issue.4, pp.1359-63, 2000.
DOI : 10.1086/315384

J. Parsonnet, M. Blaser, G. Perez-perez, N. Hargrett-bean, and R. Tauxe, Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists, Gastroenterology, vol.102, issue.1, pp.41-47, 1992.
DOI : 10.1016/0016-5085(92)91782-Y

A. Benhamiche, M. Colonna, I. Aptel, G. Launoy, P. Schaffer et al., Incidence of digestive tract cancers by region, Gastroenterol Clin Biol, vol.23, issue.10, pp.1040-1047, 1999.

C. Helicobacter and . Group, Gastric Cancer and Helicobacter pylori : a combined analysis of 12 case control cohort studies nested within prospective cohorts, Gut, vol.49, pp.347-53, 2001.

A. Hungin, P. Thomas, M. Bramble, W. Corbett, N. Idle et al., What happens to patients following open access gastroscopy? An outcome study from general practice

I. Wiklund, H. Glise, P. Jerndal, J. Carlsson, and J. Talley, Does endoscopy have a positive impact on quality of life in dyspepsia?, Gastrointestinal Endoscopy, vol.47, issue.6, pp.449-54, 1998.
DOI : 10.1016/S0016-5107(98)70243-3

A. Quadri and N. Vakil, Health-related anxiety and the effect of open-access endoscopy in US patients with dyspepsia, Alimentary Pharmacology and Therapeutics, vol.159, issue.2, pp.835-875, 2003.
DOI : 10.1001/archinte.156.8.873

J. Ofman, The effectiveness of endoscopy in the management of dyspepsia, European Journal of Gastroenterology & Hepatology, vol.11, issue.5, pp.335-381, 1999.
DOI : 10.1097/00042737-199905000-00023

A. Charachon, Evaluation de la prise en charge initiale de la dyspepsie de l'adulte en médecine générale en France, Thèse : Med : Paris 5 Necker, 200105089.

L. Gatta, C. Ricci, A. Tampieri, J. Osborn, F. Perna et al., Accuracy of breath tests using low doses of 13C-urea to diagnose Helicobacter pylori infection: a randomised controlled trial, Gut, vol.55, issue.4, pp.457-62, 2006.
DOI : 10.1136/gut.2005.078626

J. P. Gisbert and J. M. Pajares, Review article: 13C-urea breath test in the diagnosis of Helicobacter pylori infection - a critical review, Alimentary Pharmacology and Therapeutics, vol.15, issue.3, pp.1001-1018, 2004.
DOI : 10.1111/j.1083-4389.2004.00191.x

F. Perri, G. Manes, M. Neri, D. Viaira, and G. Nardone, Helicobacter pylori antigen stool test and 13C-urea breath test in patients after eradication treatments, The American Journal of Gastroenterology, vol.97, issue.11, pp.2756-62, 2002.
DOI : 10.1111/j.1572-0241.2002.07065.x

K. Dzierzanowska-fanfrat, P. Lehours, F. Mégraud, and D. Dzierzanowska, Diagnosis of Helicobacter pylori Infection, Helicobacter, vol.11, issue.s1, pp.6-13, 2006.
DOI : 10.1128/JCM.43.6.2598-2601.2005

J. Gisbert, D. Olivarez, I. Jiminez, and J. Pajares, Long-term follow-up of 13C-urea breath test results after Helicobacter pylori eradication: frequency and significance of borderline delta13CO2 values, Alimentary Pharmacology and Therapeutics, vol.95, issue.3, pp.275-80, 2006.
DOI : 10.1111/j.1083-4389.2004.00191.x

K. Mccoll, A. El-nujumi, L. Murray, E. El-omar, D. Gillen et al., The Helicobacter pylori breath test: a surrogate marker for peptic ulcer disease in dyspeptic patients., Gut, vol.40, issue.3, pp.302-308, 1997.
DOI : 10.1136/gut.40.3.302

L. Gatta, N. Vakil, C. Ricci, J. Osborn, A. Tampieri et al., Effect of Proton Pump Inhibitors and Antacid Therapy on 13C Urea Breath Tests and Stool Test for Helicobacter Pylori Infection, The American Journal of Gastroenterology, vol.93, issue.1, pp.823-832, 2004.
DOI : 10.1016/S0002-9270(98)00293-7

D. Graham, A. Opekun, F. Hammoud, Y. Yamaoka, R. Reddy et al., Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors, The American Journal of Gastroenterology, vol.84, issue.5, pp.1005-1014, 2003.
DOI : 10.1046/j.1365-2036.2002.01192.x

W. Leung, L. Hung, C. Kwok, R. Leong, and D. Ng, Follow up of serial urea breath test results in patients after consumption of antibiotics for non-gastric infections, World Journal of Gastroenterology, vol.8, issue.4, pp.703-709, 2002.
DOI : 10.1093/jac/47.4.459

B. Sheu, S. Lee, H. Yang, A. Kuo, Y. Wang et al., Selection of lower cut-off point of 13C-urea breath test is helpful to monitor Helicobacter pylori eradication after proton pump inhibitor-based triple therapy, Digestive Diseases and Sciences, vol.45, issue.7, pp.1330-1336, 2000.
DOI : 10.1023/A:1005599818959

B. Ho and B. Marshall, Accurate Diagnosis of Helicobacter pylori, Gastroenterology Clinics of North America, vol.29, issue.4, pp.853-62, 2000.
DOI : 10.1016/S0889-8553(05)70152-7

L. Lim, K. Yeoh, B. Ho, and S. Lim, rapid blood tests in a multi-ethnic Asian population, World Journal of Gastroenterology, vol.11, issue.42, pp.6681-6684, 2005.
DOI : 10.1046/j.1365-2036.2002.01169.x

P. Moayyedi, B. Delaney, N. Vakil, D. Forman, and J. Talley, The efficacy of proton pump inhibitors in nonulcer dyspepsia: A systematic review and economic analysis, Gastroenterology, vol.127, issue.5, pp.1329-1366, 2004.
DOI : 10.1053/j.gastro.2004.08.026

W. Wong, B. Wong, W. Hung, Y. Kee, and A. Yip, Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients, Gut, vol.51, issue.4, pp.502-508, 2002.
DOI : 10.1136/gut.51.4.502

D. Peura, O. Thomas, G. Kovacs, D. Metz, N. Siepman et al., Lansoprazole in the treatment of functional dyspepsia: Two Double-Blind, Randomized, Placebo-Controlled trials, The American Journal of Medicine, vol.116, issue.11, pp.740-748, 2004.
DOI : 10.1016/j.amjmed.2004.01.008

N. Talley, V. Meineche-schmidt, P. Paré, M. Duckworth, P. Räisänen et al., Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies), Alimentary Pharmacology and Therapeutics, vol.10, issue.11, pp.1055-65, 1998.
DOI : 10.1097/00042737-199802000-00004

N. Talley and K. Lauritsen, The potential role of acid suppression in functional dyspepsia: the BOND, OPERA, PILOT, and ENCORE studies, Gut, vol.50, issue.Supplement 4, pp.36-41, 2002.
DOI : 10.1136/gut.50.suppl_4.iv36

A. Blum, R. Arnold, M. Stolte, M. Fischer, H. Koelz et al., Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status, Gut, vol.47, issue.4, pp.473-80, 2000.
DOI : 10.1136/gut.47.4.473

S. Panter, O. Flanagan, H. Bramble, N. Hungin, and A. , Empirical use of antisecretory drug therapy delays diagnosis of upper gastrointestinal adenocarcinoma but does not effect outcome, Alimentary Pharmacology and Therapeutics, vol.3, issue.133, pp.981-989, 2004.
DOI : 10.1016/S0344-0338(78)80028-4

M. Bramble, Z. Suvakovic, and A. Hungin, Detection of upper gastrointestinal cancer in patients taking antisecretory therapy prior to gastroscopy, Gut, vol.46, issue.4, pp.464-471, 2000.
DOI : 10.1136/gut.46.4.464

N. Talley, Therapeutic Options in Nonulcer Dyspepsia, Journal of Clinical Gastroenterology, vol.32, issue.4, pp.286-93, 2001.
DOI : 10.1097/00004836-200104000-00004

P. Ducrotté, Traitement d???une dyspepsie, Gastroent??rologie Clinique et Biologique, vol.30, issue.3, pp.408-422, 2006.
DOI : 10.1016/S0399-8320(06)73195-5

S. Soo, P. Moayyedi, J. Deeks, B. Delaney, M. Lewis et al., Psychological interventions for non-ulcer dyspepsia, Cochrane Database Syst Rev, issue.2, p.2301, 2004.

P. Sharma and N. Vakil, Helicobacter pylori and reflux disease, Alimentary Pharmacology and Therapeutics, vol.19, issue.6, pp.297-305, 2003.
DOI : 10.1016/S0016-5085(98)70364-6

K. Mccoll, A. El-nujumi, L. Murray, E. El-omar, A. Dickson et al., Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer, Gut, vol.42, issue.5, pp.618-640, 1998.
DOI : 10.1136/gut.42.5.618

M. Chiorean, G. Locke, A. Zinsmeister, C. Schleck, and J. Melton, Changing rates of Helicobacter pylori testing and treatment in patients with peptic ulcer disease, The American Journal of Gastroenterology, vol.34, issue.12, pp.3015-3037, 2002.
DOI : 10.1097/00004836-199701000-00002

A. Ciociola, D. Mcsorley, K. Turner, D. Sykes, and J. Palmer, Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated, The American Journal of Gastroenterology, vol.91, issue.8, pp.1834-1874, 1999.
DOI : 10.1016/0016-5085(92)91716-H

J. De-korwin and M. Frédéric, Gastrites chroniques, EMC - Gastro-ent??rologie, vol.1, issue.1, pp.9-017
DOI : 10.1016/S1155-1968(03)00072-5

J. Kusters, A. Van-vliet, and E. Kuipers, Pathogenesis of Helicobacter pylori Infection, Clinical Microbiology Reviews, vol.19, issue.3, pp.449-90, 2006.
DOI : 10.1128/CMR.00054-05

J. Huang, S. Sridhar, and R. Hunt, Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis, The Lancet, vol.359, issue.9300, pp.14-22, 2002.
DOI : 10.1016/S0140-6736(02)07273-2

X. Roblin, Ulc??re duod??nal et infection ?? Helicobacter pylori, Gastroent??rologie Clinique et Biologique, vol.31, issue.12, pp.1119-1139, 2007.
DOI : 10.1016/S0399-8320(07)78347-1

N. Uemura, S. Okamoto, S. Yamamoto, N. Matsumura, S. Yamaguchi et al., Infection and the Development of Gastric Cancer, New England Journal of Medicine, vol.345, issue.11, pp.784-793, 2001.
DOI : 10.1056/NEJMoa001999

N. Broutet, A. Sarasqueta, F. Cantet, L. D. Megraud, and F. , Is there a link between the variation of gastric cancer mortality and differences in Helicobacter pylori prevalence in different regions of France, Gastroenterol Clin Biol, vol.23, pp.6-7754, 1999.

J. Huang, G. Zheng, K. Sumanac, J. Irvine, and R. Hunt, Meta-analysis of the relationship between cagA seropositivity and gastric cancer, Gastroenterology, vol.125, issue.6, pp.1926-1933, 2004.
DOI : 10.1053/j.gastro.2003.08.033

C. Figueiredo, J. Machado, P. Pharoah, R. Seruca, S. Sousa et al., Helicobacter pylori and Interleukin 1 Genotyping: An Opportunity to Identify High-Risk Individuals for Gastric Carcinoma, CancerSpectrum Knowledge Environment, vol.94, issue.22, pp.1680-1687, 2002.
DOI : 10.1093/jnci/94.22.1680

E. El-omar, K. Oien, L. Murray, A. El-nujumi, A. Wirz et al., Increased prevalence of precancerous changes in relatives of gastric cancer patients: Critical role of H. pylori, Gastroenterology, vol.118, issue.1, pp.22-30, 2000.
DOI : 10.1016/S0016-5085(00)70410-0

T. Rokkas, D. Pistiolas, P. Sechopoulos, I. Robotis, and G. Margantinis, The Long-term Impact of Helicobacter??pylori Eradication on Gastric Histology: a Systematic Review and Meta-analysis, Helicobacter, vol.11, issue.1, pp.32-40, 2007.
DOI : 10.1046/j.1365-2036.2002.01346.x

T. Barbara, Dyspepsie non ulcéreuse et Helicobacter pylori : Existe-t-il un profil symptomatique spécifique? Etude prospective chez 258 patients, Thèse : Med : UHP Nancy, 199711070.

J. Delchier and . Helicobacter-pylori, Questions au Professeur Jean-Charles Delchier, Gastroent??rologie Clinique et Biologique, vol.31, issue.12, pp.1121-1124, 2007.
DOI : 10.1016/S0399-8320(07)78348-3

A. Courillon-mallet, Quand et comment contrôler l'éradication de Helicobacter pylori après un traitement de première ligne?, Gastroenterol Clin Biol, vol.27, issue.3, pp.473-480, 2003.

P. Moayyedi, R. Feltbower, J. Brown, S. Mason, J. Mason et al., Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial, The Lancet, vol.355, issue.9216, pp.1665-1674, 2000.
DOI : 10.1016/S0140-6736(00)02236-4

N. Talley, N. Vakil, D. Ballard, and B. Fennerty, in Patients with Nonulcer Dyspepsia, New England Journal of Medicine, vol.341, issue.15, pp.1106-1117, 1999.
DOI : 10.1056/NEJM199910073411502

E. Kuipers, G. Nelis, E. Klinkenberg-knol, P. Snel, D. Goldfain et al., Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial, Gut, vol.53, issue.1, pp.12-20, 2004.
DOI : 10.1136/gut.53.1.12

L. Laine and J. Sugg, Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies, The American Journal of Gastroenterology, vol.35, issue.12, pp.2992-2999, 2002.
DOI : 10.1067/mge.2002.122617

P. Moayyedi, C. Bardhan, L. Young, M. Dixon, L. Brown et al., Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease, Gastroenterology, vol.121, issue.5, pp.1120-1126, 2001.
DOI : 10.1053/gast.2001.29332

N. Vakil, N. Talley, M. Stolte, M. Sundin, P. Junghard et al., Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro-oesophageal reflux disease in Western patients with non-ulcer dyspepsia, Alimentary Pharmacology and Therapeutics, vol.32, issue.1, pp.55-63, 2006.
DOI : 10.1111/j.1572-0241.2003.08724.x

A. Raghunath, A. Hungin, D. Wooff, and S. Childs, The effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis, Alimentary Pharmacology and Therapeutics, vol.16, issue.1, pp.733-777, 2004.
DOI : 10.1046/j.1365-2036.2002.01169.x

N. Vakil, B. Traxler, and D. Levine, Symptom Response and Healing of Erosive Esophagitis with Proton-Pump Inhibitors in Patients with Helicobacter pylori Infection, The American Journal of Gastroenterology, vol.115, issue.1, pp.1437-1478, 2004.
DOI : 10.1111/j.1572-0241.2001.05263.x

N. Wit, W. Boer, H. Geldof, B. Hazelhoff, P. Bergmans et al., Treatment of gastro-oesophageal reflux disease with rabeprazole in primary and secondary care: does Helicobacter pylori infection affect proton pump inhibitor effectiveness?, Alimentary Pharmacology and Therapeutics, vol.98, issue.4, pp.451-459, 2004.
DOI : 10.1016/S1590-8658(01)80100-6

C. Fallone, A. Barkun, S. Mayrand, G. Wakil, G. Friedman et al., There is no difference in the disease severity of gastro-oesophageal reflux disease between patients infected and not infected with Helicobacter pylori, Alimentary Pharmacology and Therapeutics, vol.45, issue.1, pp.761-769, 2004.
DOI : 10.1007/BF00191963

A. Leodolter, M. Kulig, H. Brasch, W. Meyer-sabellek, S. Willich et al., A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori-associated gastric or duodenal ulcer, Alimentary Pharmacology and Therapeutics, vol.15, issue.12, pp.1949-58, 2001.
DOI : 10.1053/gast.1997.v113.pm9322501

G. Nervi, S. Liatopoulou, L. Cavallaro, A. Gnocchi, D. Bo et al., Does Helicobacter pylori infection eradication modify peptic ulcer prevalence A 10 years' endoscopical survey, World Journal of Gastroenterology, vol.12, issue.15, pp.122398-2401, 2006.
DOI : 10.1023/A:1012731614075

G. Forbes, M. Glaser, D. Cullen, J. Warren, K. Christiansen et al., Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up, The Lancet, vol.343, issue.8892, pp.258-60, 1994.
DOI : 10.1016/S0140-6736(94)91111-8

A. Ford, B. Delaney, D. Forman, and P. Moayyedi, Eradication Therapy in Helicobacter pylori Positive Peptic Ulcer Disease: Systematic Review and Economic Analysis, The American Journal of Gastroenterology, vol.312, issue.2, pp.1833-55, 2004.
DOI : 10.1136/bmj.312.7027.349

K. Lai, S. Lam, K. Chu, B. Wong, W. Hui et al., Lansoprazole for the Prevention of Recurrences of Ulcer Complications from Long-Term Low-Dose Aspirin Use, New England Journal of Medicine, vol.346, issue.26, pp.2033-2041, 2002.
DOI : 10.1056/NEJMoa012877

F. Chan, K. To, J. Wu, M. Yung, W. Leung et al., Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial, The Lancet, vol.359, issue.9300, pp.9-13, 2002.
DOI : 10.1016/S0140-6736(02)07272-0

C. Hawkey, Z. Tulassay, L. Szczepanski, C. Van-rensburg, A. Filipowicz-sosnowska et al., Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs, European Journal of Gastroenterology & Hepatology, vol.10, issue.11, pp.1016-1037, 1998.
DOI : 10.1097/00042737-199811000-00018

F. Chan, S. Chung, B. Suen, Y. Lee, W. Leung et al., Infection Who Are Taking Low-Dose Aspirin or Naproxen, New England Journal of Medicine, vol.344, issue.13, pp.967-73, 2001.
DOI : 10.1056/NEJM200103293441304

K. Lai, S. Lam, K. Chu, W. Hui, B. Wong et al., Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users - a randomized trial, Alimentary Pharmacology and Therapeutics, vol.91, issue.8, pp.829-865, 2003.
DOI : 10.1136/gut.51.3.336

V. Sharma, A. Sahai, F. Corder, and C. Howden, Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage, Alimentary Pharmacology and Therapeutics, vol.15, issue.12, pp.1939-1986, 2001.
DOI : 10.1111/j.1572-0241.1998.00684.x

C. Liu, C. Lee, C. Chan, T. Tu, C. Liao et al., Maintenance Treatment Is Not Necessary After Helicobacter pylori Eradication and Healing of Bleeding Peptic Ulcer, Archives of Internal Medicine, vol.163, issue.17, pp.2020-2024, 2003.
DOI : 10.1001/archinte.163.17.2020

J. Gisbert, S. Khorrami, F. Carballo, X. Calvet, G. E. Dominguez-munoz et al., Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer, Alimentary Pharmacology and Therapeutics, vol.12, issue.3, pp.617-646, 2004.
DOI : 10.1111/j.1572-0241.2002.05904.x

E. Kuipers and P. Sipponen, Helicobacter pylori Eradication for the Prevention of Gastric Cancer, Helicobacter, vol.128, issue.s1, pp.52-59, 2006.
DOI : 10.1136/gut.53.1.12

W. Leung, S. Lin, J. Ching, K. To, E. Ng et al., Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication, Gut, vol.53, issue.9, pp.1244-1253, 2004.
DOI : 10.1136/gut.2003.034629

C. Ley, A. Mohar, J. Guarner, R. Herrera-goepfert, L. Figueroa et al., Helicobacter pylori Eradication and Gastric Preneoplastic Conditions: A Randomized, Double-Blind, Placebo-Controlled Trial, Cancer Epidemiology Biomarkers & Prevention, vol.13, issue.1, pp.4-10, 2004.
DOI : 10.1158/1055-9965.EPI-03-0124

P. Correa, E. Fontham, J. Bravo, L. Bravo, B. Ruiz et al., Chemoprevention of Gastric Dysplasia: Randomized Trial of Antioxidant Supplements and Anti-Helicobacter pylori Therapy, Journal of the National Cancer Institute, vol.92, issue.23, pp.1881-1889, 2000.
DOI : 10.1093/jnci/92.23.1881

B. Wong, S. Lam, W. Wong, J. Chen, T. Zheng et al., Helicobacter pylori Eradication to Prevent Gastric Cancer in a High-Risk Region of China, JAMA, vol.291, issue.2, pp.187-94, 2004.
DOI : 10.1001/jama.291.2.187

R. Mera, E. Fontham, L. Bravo, J. Bravo, M. Piazuelo et al., Long term follow up of patients treated for Helicobacter pylori infection, Gut, vol.54, issue.11, pp.1536-1576, 2005.
DOI : 10.1136/gut.2005.072009

S. Take, M. Mizuno, K. Ishiki, Y. Nagahara, T. Yoshida et al., The Effect of Eradicating Helicobacter Pylori on the Development of Gastric Cancer in Patients with Peptic Ulcer Disease, The American Journal of Gastroenterology, vol.125, issue.5, pp.1037-1079, 2005.
DOI : 10.1007/s10120-003-0265-0

S. Nakamura, T. Matsumoto, H. Suekane, S. Nakamura, H. Matsumoto et al., Long-term clinical outcome ofHelicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment, Cancer, vol.60, issue.3, pp.532-572, 2005.
DOI : 10.3109/10428199909093738

S. Lee, J. Kim, J. Lee, Y. Kim, P. Rhee et al., Synchronous Adenocarcinoma and Mucosa-associated Lymphoid Tissue (MALT) Lymphoma in a Single Stomach, Japanese Journal of Clinical Oncology, vol.35, issue.10, pp.591-595, 2005.
DOI : 10.1016/S0140-6736(94)91254-8

C. Montalban and F. Norman, eradication and beyond, Expert Review of Anticancer Therapy, vol.100, issue.3, pp.361-71, 2006.
DOI : 10.1200/JCO.2005.05.660

L. Chen, J. Lin, J. Tai, G. Chen, H. Yeh et al., Long-Term Results of Anti??? Helicobacter pylori Therapy in Early-Stage Gastric High-Grade Transformed MALT Lymphoma, JNCI: Journal of the National Cancer Institute, vol.97, issue.18, pp.1345-53, 2005.
DOI : 10.1200/JCO.2004.10.087

N. Talley, J. Janssens, K. Lauritsen, I. Racz, and E. Bolling-sternvald, Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12??months' follow up, BMJ, vol.318, issue.7187, pp.833-840, 1999.
DOI : 10.1136/bmj.318.7187.833

S. Veldhuyzen-van-zanten, N. Talley, A. Blum, E. Bolling-sternevald, M. Sundin et al., Combined analysis of the ORCHID and OCAY studies: does eradication of Helicobacter pylori lead to sustained improvement in functional dyspepsia symptoms?, Gut, vol.50, issue.Supplement 4, pp.26-30, 2002.
DOI : 10.1136/gut.50.suppl_4.iv26

K. Mccoll, L. Murray, E. El-omar, A. Dickson, A. El-nujumi et al., Infection in Patients with Nonulcer Dyspepsia, New England Journal of Medicine, vol.339, issue.26, pp.1869-74, 1998.
DOI : 10.1056/NEJM199812243392601

L. Laine, P. Schoenfeld, and B. Fennerty, in Patients with Nonulcer Dyspepsia, Annals of Internal Medicine, vol.134, issue.5, pp.361-370, 2001.
DOI : 10.7326/0003-4819-134-5-200103060-00008

P. Moayyedi, S. Soo, J. Deeks, B. Delaney, A. Harris et al., Eradication of Helicobacter pylori for non-ulcer dyspepsia, Cochrane Database Syst Rev, issue.2, p.2096, 2000.

J. Mason, A. Raghunath, A. Hungin, and W. Jackson, Helicobacter pylori eradication in long-term proton pump inhibitor users is highly cost-effective : economic analysis of the HELPUP trial, Aliment Pharmacol Ther, vol.28, pp.11-121297, 2008.

D. Mcnamara, M. Buckley, J. Gilvarry, O. Morain, and C. , Does Helicobacter pylori Eradication Affect Symptoms in Nonulcer Dyspepsia: A 5-Year Follow-Up Study, Helicobacter, vol.11, issue.318, pp.317-338, 2002.
DOI : 10.1097/00042737-199906001-00006

. Afssaps, Prise en charge thérapeutique de l'éradication de Helicobacter pylori chez l'adulte et chez l'enfant, 2005.

A. Zullo, D. Vaira, N. Vakil, C. Hassan, L. Gatta et al., High eradication rates of Helicobacter pylori with a new sequential treatment, Alimentary Pharmacology and Therapeutics, vol.34, issue.5, pp.719-745, 2003.
DOI : 10.1046/j.1365-2036.2000.00719.x

M. Vergara, M. Vallve, J. Gisbert, and X. Calvet, Meta-analysis: comparative efficacy of different proton-pump inhibitors in triple therapy for Helicobacter pylori eradication, Alimentary Pharmacology and Therapeutics, vol.11, issue.6, pp.647-54, 2003.
DOI : 10.1046/j.1365-2036.2002.01270.x

C. Martin, Procédures d'éradication et de contrôle d'éradication. Une étude prospective comparative entre 2 centres de gastro-entérologie en Lorraine, Thèse : Med : UHP NANCY, 2010.

S. Bruley-des-varannes, Quel traitement peut-on proposer après un échec d'éradication de Helicobacter pylori?, Gastroenterol Clin Biol, vol.27, issue.3, pp.478-83, 2003.

H. Lamouliatte, F. Mégraud, J. Delchier, J. Bretagne, A. Courillon-mallet et al., Second-line treatment for failure to eradicate Helicobacter pylori: a randomized trial comparing four treatment strategies, Alimentary Pharmacology and Therapeutics, vol.86, issue.8, pp.791-798, 2003.
DOI : 10.1080/003655201300191941

F. Mégraud, H pylori antibiotic resistance: prevalence, importance, and advances in testing, Gut, vol.53, issue.9, pp.1374-84, 2004.
DOI : 10.1136/gut.2003.022111

F. Megraud and H. Lamouliatte, Review article: the treatment of refractory Helicobacter pylori infection, Alimentary Pharmacology and Therapeutics, vol.45, issue.345, pp.1333-1376, 2003.
DOI : 10.1128/JCM.41.1.397-402.2003

B. Mcmahon, T. Henessy, J. Bensler, D. Burden, A. Parkinson et al., Infections, Annals of Internal Medicine, vol.139, issue.6, pp.463-70, 2003.
DOI : 10.7326/0003-4819-139-6-200309160-00008

J. Lee, J. Shin, I. Roe, S. Sohn, J. Lee et al., Impact of Clarithromycin Resistance on Eradication of Helicobacter pylori in Infected Adults, Antimicrobial Agents and Chemotherapy, vol.49, issue.4, pp.1600-1603, 2005.
DOI : 10.1128/AAC.49.4.1600-1603.2005

J. Gisbert and F. De-la-morena, Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure, Alimentary Pharmacology and Therapeutics, vol.83, issue.2, pp.35-44, 2006.
DOI : 10.1111/j.1365-2036.2005.02622.x

S. Miehlke, K. Hansky, W. Schneider-brachert, C. Kirsch, A. Morgner et al., Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin, Alimentary Pharmacology and Therapeutics, vol.50, issue.2, pp.395-403, 2006.
DOI : 10.1067/mcp.2001.113959

.. Helicobacter-pylori, 13-10 comparaison du traitement en cas de persistance des symptômes malgré une éradication efficace, tableau 3.4.13-9 comparaison du traitement en, p.95

G. La, 72 figure 3.4.2-3 ensemble des résultats attendus à la gastroscopie en fonction de tous les médecins répondeurs, figure 3.4.2-2 autres résultats attendus, p.74